BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 30192654)

  • 1. Dexamethasone decreases the autotaxin-lysophosphatidate-inflammatory axis in adipose tissue: implications for the metabolic syndrome and breast cancer.
    Meng G; Tang X; Yang Z; Zhao Y; Curtis JM; McMullen TPW; Brindley DN
    FASEB J; 2019 Feb; 33(2):1899-1910. PubMed ID: 30192654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implications for breast cancer treatment from increased autotaxin production in adipose tissue after radiotherapy.
    Meng G; Tang X; Yang Z; Benesch MGK; Marshall A; Murray D; Hemmings DG; Wuest F; McMullen TPW; Brindley DN
    FASEB J; 2017 Sep; 31(9):4064-4077. PubMed ID: 28539367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of autotaxin expression and secretion by lysophosphatidate and sphingosine 1-phosphate.
    Benesch MG; Zhao YY; Curtis JM; McMullen TP; Brindley DN
    J Lipid Res; 2015 Jun; 56(6):1134-44. PubMed ID: 25896349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Adipose Tissue-Derived Autotaxin, Lysophosphatidate Signaling, and Inflammation in the Progression and Treatment of Breast Cancer.
    Brindley DN; Tang X; Meng G; Benesch MGK
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32824846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-induced inflammation in mammary adipose tissue stimulates a vicious cycle of autotaxin expression and breast cancer progression.
    Benesch MG; Tang X; Dewald J; Dong WF; Mackey JR; Hemmings DG; McMullen TP; Brindley DN
    FASEB J; 2015 Sep; 29(9):3990-4000. PubMed ID: 26071407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signalling by lysophosphatidate and its health implications.
    Hemmings DG; Brindley DN
    Essays Biochem; 2020 Sep; 64(3):547-563. PubMed ID: 32451553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the autotaxin-lysophosphatidate axis in the development of resistance to cancer therapy.
    Tang X; Benesch MGK; Brindley DN
    Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Aug; 1865(8):158716. PubMed ID: 32305571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammary Adipose Tissue-Derived Lysophospholipids Promote Estrogen Receptor-Negative Mammary Epithelial Cell Proliferation.
    Volden PA; Skor MN; Johnson MB; Singh P; Patel FN; McClintock MK; Brady MJ; Conzen SD
    Cancer Prev Res (Phila); 2016 May; 9(5):367-78. PubMed ID: 26862086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of lysophosphatidate signaling by autotaxin and lipid phosphate phosphatases with respect to tumor progression, angiogenesis, metastasis and chemo-resistance.
    Samadi N; Bekele R; Capatos D; Venkatraman G; Sariahmetoglu M; Brindley DN
    Biochimie; 2011 Jan; 93(1):61-70. PubMed ID: 20709140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decrease in circulating autotaxin by oral administration of prednisolone.
    Sumida H; Nakamura K; Yanagida K; Ohkawa R; Asano Y; Kadono T; Tamaki K; Igarashi K; Aoki J; Sato S; Ishii S; Shimizu T; Yatomi Y
    Clin Chim Acta; 2013 Jan; 415():74-80. PubMed ID: 23063960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of autotaxin/lysophosphatidic acid signaling in obesity and impaired glucose homeostasis.
    Rancoule C; Dusaulcy R; Tréguer K; Grès S; Attané C; Saulnier-Blache JS
    Biochimie; 2014 Jan; 96():140-3. PubMed ID: 23639740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ADSCs and adipocytes are the main producers in the autotaxin-lysophosphatidic acid axis of breast cancer and healthy mammary tissue in vitro.
    Schmid R; Wolf K; Robering JW; Strauß S; Strissel PL; Strick R; Rübner M; Fasching PA; Horch RE; Kremer AE; Boos AM; Weigand A
    BMC Cancer; 2018 Dec; 18(1):1273. PubMed ID: 30567518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dexamethasone Attenuates X-Ray-Induced Activation of the Autotaxin-Lysophosphatidate-Inflammatory Cycle in Breast Tissue and Subsequent Breast Fibrosis.
    Meng G; Wuest M; Tang X; Dufour J; McMullen TPW; Wuest F; Murray D; Brindley DN
    Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32325715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adipose-specific disruption of autotaxin enhances nutritional fattening and reduces plasma lysophosphatidic acid.
    Dusaulcy R; Rancoule C; Grès S; Wanecq E; Colom A; Guigné C; van Meeteren LA; Moolenaar WH; Valet P; Saulnier-Blache JS
    J Lipid Res; 2011 Jun; 52(6):1247-1255. PubMed ID: 21421848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autotaxin-LPA-LPP3 Axis in Energy Metabolism and Metabolic Disease.
    Jose A; Kienesberger PC
    Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autotaxin and chronic inflammatory diseases.
    Magkrioti C; Galaris A; Kanellopoulou P; Stylianaki EA; Kaffe E; Aidinis V
    J Autoimmun; 2019 Nov; 104():102327. PubMed ID: 31471142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blocking gp130 signaling suppresses autotaxin expression in adipocytes and improves insulin sensitivity in diet-induced obesity.
    Sun S; Wang R; Song J; Guan M; Li N; Zhang X; Zhao Z; Zhang J
    J Lipid Res; 2017 Nov; 58(11):2102-2113. PubMed ID: 28874440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the Autotaxin-LPA Pathway in Dexamethasone-Induced Fibrotic Responses and Extracellular Matrix Production in Human Trabecular Meshwork Cells.
    Honjo M; Igarashi N; Nishida J; Kurano M; Yatomi Y; Igarashi K; Kano K; Aoki J; Aihara M
    Invest Ophthalmol Vis Sci; 2018 Jan; 59(1):21-30. PubMed ID: 29305605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autotaxin-LPA signaling contributes to obesity-induced insulin resistance in muscle and impairs mitochondrial metabolism.
    D'Souza K; Nzirorera C; Cowie AM; Varghese GP; Trivedi P; Eichmann TO; Biswas D; Touaibia M; Morris AJ; Aidinis V; Kane DA; Pulinilkunnil T; Kienesberger PC
    J Lipid Res; 2018 Oct; 59(10):1805-1817. PubMed ID: 30072447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased Autotaxin Levels in Severe COVID-19, Correlating with IL-6 Levels, Endothelial Dysfunction Biomarkers, and Impaired Functions of Dendritic Cells.
    Nikitopoulou I; Fanidis D; Ntatsoulis K; Moulos P; Mpekoulis G; Evangelidou M; Vassiliou AG; Dimakopoulou V; Jahaj E; Tsipilis S; Orfanos SE; Dimopoulou I; Angelakis E; Akinosoglou K; Vassilaki N; Tzouvelekis A; Kotanidou A; Aidinis V
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.